Antisense & RNAi Therapeutics Market Report

Global Antisense & RNAi Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 22, 2021
  • PAGES：209
  • REPORT CODE：GMM651031
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Antisense & RNAi Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Antisense & RNAi Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Antisense & RNAi Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Antisense & RNAi Therapeutics Market Segmentations:

    By Players:

    • Olix Pharmaceuticals

    • Mirna Therapeutics Inc

    • Ionis Pharmaceuticals

    • Rexahn Pharmaceuticals

    • Enzon Pharmaceuticals Inc

    • Acuitas Therapeutics

    • Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Alnylam Pharmaceuticals

    • Silence Therapeutics Plc

    • Antisense Therapeutics Ltd

    • GlaxoSmithKline Plc

    • OncoGeneX Pharmaceuticals

    • Bio-Path Holdings Inc

    • Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Benitec Biopharma

    • Lorus Therapeutics (Aptose Biosciences)

    • Sanofi-Genzyme

    • Gene Signal

    • Gradalis

    • Quark Pharmaceuticals

    • miRagen Therapeutics

    • Marina Biosciences

    • iCo Therapeutics

    By Types:

    • RNA Interference

    • SiRNA

    • MiRNA

    • Antisense RNA

    By End-User:

    • Oncology

    • Cardiovascular

    • Renal

    • Neurodegenerative

    • Respiratory

    • Genetic

    • Infectious Diseases

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antisense & RNAi Therapeutics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026

      • 1.3.2 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of SiRNA from 2014 to 2026

      • 1.3.3 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of MiRNA from 2014 to 2026

      • 1.3.4 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Cardiovascular from 2014 to 2026

      • 1.4.3 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Renal from 2014 to 2026

      • 1.4.4 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Neurodegenerative from 2014 to 2026

      • 1.4.5 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Respiratory from 2014 to 2026

      • 1.4.6 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Genetic from 2014 to 2026

      • 1.4.7 Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Antisense & RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Antisense & RNAi Therapeutics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antisense & RNAi Therapeutics by Major Types

      • 3.4.1 Antisense & RNAi Therapeutics Market Size and Growth Rate of RNA Interference

      • 3.4.2 Antisense & RNAi Therapeutics Market Size and Growth Rate of SiRNA

      • 3.4.3 Antisense & RNAi Therapeutics Market Size and Growth Rate of MiRNA

      • 3.4.4 Antisense & RNAi Therapeutics Market Size and Growth Rate of Antisense RNA

    4 Segmentation of Antisense & RNAi Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antisense & RNAi Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Oncology

      • 4.4.2 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Cardiovascular

      • 4.4.3 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Renal

      • 4.4.4 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Neurodegenerative

      • 4.4.5 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Respiratory

      • 4.4.6 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Genetic

      • 4.4.7 Market Size and Growth Rate of Antisense & RNAi Therapeutics in Infectious Diseases

    5 Market Analysis by Major Regions

    • 5.1 Global Antisense & RNAi Therapeutics Production Analysis by Major Regions

    • 5.2 Global Antisense & RNAi Therapeutics Consumption Analysis by Major Regions

    • 5.3 Global Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Commodity of Antisense & RNAi Therapeutics Market in Major Countries

    • 6.1 Top 5 Export Countries in Antisense & RNAi Therapeutics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Antisense & RNAi Therapeutics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Antisense & RNAi Therapeutics Landscape Analysis

    • 7.1 North America Antisense & RNAi Therapeutics Landscape Analysis by Major Types

    • 7.2 North America Antisense & RNAi Therapeutics Landscape Analysis by Major End-Users

    • 7.3 North America Antisense & RNAi Therapeutics Landscape Analysis by Major Countries

      • 7.3.1 United States Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 7.3.2 Canada Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 7.3.3 Mexico Antisense & RNAi Therapeutics Market Volume and Growth Rate

    8 Europe Antisense & RNAi Therapeutics Landscape Analysis

    • 8.1 Europe Antisense & RNAi Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe Antisense & RNAi Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe Antisense & RNAi Therapeutics Landscape Analysis by Major Countries

      • 8.3.1 Germany Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.3 France Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.6 Spain Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.7 Belgium Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.8 Poland Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.9 Russia Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.10 Turkey Antisense & RNAi Therapeutics Market Volume and Growth Rate

    9 Asia Pacific Antisense & RNAi Therapeutics Landscape Analysis

    • 9.1 Asia Pacific Antisense & RNAi Therapeutics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Antisense & RNAi Therapeutics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Antisense & RNAi Therapeutics Landscape Analysis by Major Countries

      • 9.3.1 China Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.2 Japan Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.4 India Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.6 South Korea Antisense & RNAi Therapeutics Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Antisense & RNAi Therapeutics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.2 Brazil Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.3 Nigeria Antisense & RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.4 South Africa Antisense & RNAi Therapeutics Market Volume and Growth Rate 

      • 10.3.5 Argentina Antisense & RNAi Therapeutics Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Olix Pharmaceuticals

      • 11.1.1 Olix Pharmaceuticals Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Mirna Therapeutics Inc

      • 11.2.1 Mirna Therapeutics Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Ionis Pharmaceuticals

      • 11.3.1 Ionis Pharmaceuticals Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Rexahn Pharmaceuticals

      • 11.4.1 Rexahn Pharmaceuticals Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Enzon Pharmaceuticals Inc

      • 11.5.1 Enzon Pharmaceuticals Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Acuitas Therapeutics

      • 11.6.1 Acuitas Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

      • 11.7.1 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Alnylam Pharmaceuticals

      • 11.8.1 Alnylam Pharmaceuticals Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Silence Therapeutics Plc

      • 11.9.1 Silence Therapeutics Plc Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Antisense Therapeutics Ltd

      • 11.10.1 Antisense Therapeutics Ltd Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 GlaxoSmithKline Plc

      • 11.11.1 GlaxoSmithKline Plc Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 OncoGeneX Pharmaceuticals

      • 11.12.1 OncoGeneX Pharmaceuticals Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Bio-Path Holdings Inc

      • 11.13.1 Bio-Path Holdings Inc Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

      • 11.14.1 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Benitec Biopharma

      • 11.15.1 Benitec Biopharma Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Lorus Therapeutics (Aptose Biosciences)

      • 11.16.1 Lorus Therapeutics (Aptose Biosciences) Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Sanofi-Genzyme

      • 11.17.1 Sanofi-Genzyme Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Gene Signal

      • 11.18.1 Gene Signal Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Gradalis

      • 11.19.1 Gradalis Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Quark Pharmaceuticals

      • 11.20.1 Quark Pharmaceuticals Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 miRagen Therapeutics

      • 11.21.1 miRagen Therapeutics Company Profile and Recent Development

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    • 11.22 Marina Biosciences

      • 11.22.1 Marina Biosciences Company Profile and Recent Development

      • 11.22.2 Market Performance

      • 11.22.3 Product and Service Introduction

    • 11.23 iCo Therapeutics

      • 11.23.1 iCo Therapeutics Company Profile and Recent Development

      • 11.23.2 Market Performance

      • 11.23.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 86 Figures and 134 Tables)

    • Figure Product Picture

    • Figure Antisense & RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026

    • Figure Antisense & RNAi Therapeutics Market Size and Growth Rate of SiRNA from 2014 to 2026

    • Figure Antisense & RNAi Therapeutics Market Size and Growth Rate of MiRNA from 2014 to 2026

    • Figure Antisense & RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Renal from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Neurodegenerative from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Respiratory from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Genetic from 2014 to 2026

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Antisense & RNAi Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Antisense & RNAi Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antisense & RNAi Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Antisense & RNAi Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of RNA Interference

    • Figure Market Size and Growth Rate of SiRNA

    • Figure Market Size and Growth Rate of MiRNA

    • Figure Market Size and Growth Rate of Antisense RNA

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Antisense & RNAi Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Antisense & RNAi Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Renal

    • Figure Market Size and Growth Rate of Neurodegenerative

    • Figure Market Size and Growth Rate of Respiratory

    • Figure Market Size and Growth Rate of Genetic

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Table Global Antisense & RNAi Therapeutics Production by Major Regions

    • Table Global Antisense & RNAi Therapeutics Production Share by Major Regions

    • Figure Global Antisense & RNAi Therapeutics Production Share by Major Regions in 2014

    • Figure Global Antisense & RNAi Therapeutics Production Share by Major Regions in 2018

    • Figure Global Antisense & RNAi Therapeutics Production Share by Major Regions in 2026

    • Table Global Antisense & RNAi Therapeutics Consumption by Major Regions

    • Table Global Antisense & RNAi Therapeutics Consumption Share by Major Regions

    • Figure Global Antisense & RNAi Therapeutics Consumption Share by Major Regions in 2014

    • Figure Global Antisense & RNAi Therapeutics Consumption Share by Major Regions in 2018

    • Figure Global Antisense & RNAi Therapeutics Consumption Share by Major Regions in 2026

    • Table North America Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Antisense & RNAi Therapeutics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Antisense & RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table North America Antisense & RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Types in 2014

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Types in 2018

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Types in 2026

    • Table North America Antisense & RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table North America Antisense & RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table North America Antisense & RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America Antisense & RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Types in 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe Antisense & RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Europe Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure Germany Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Types in 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure China Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandAntisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Antisense & RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Antisense & RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Olix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Olix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Olix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Olix Pharmaceuticals

    • Table Product and Service Introduction of Olix Pharmaceuticals

    • Table Company Profile and Development Status of Mirna Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirna Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Mirna Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Mirna Therapeutics Inc

    • Table Product and Service Introduction of Mirna Therapeutics Inc

    • Table Company Profile and Development Status of Ionis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals

    • Table Product and Service Introduction of Ionis Pharmaceuticals

    • Table Company Profile and Development Status of Rexahn Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rexahn Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Rexahn Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Rexahn Pharmaceuticals

    • Table Product and Service Introduction of Rexahn Pharmaceuticals

    • Table Company Profile and Development Status of Enzon Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enzon Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Enzon Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Enzon Pharmaceuticals Inc

    • Table Product and Service Introduction of Enzon Pharmaceuticals Inc

    • Table Company Profile and Development Status of Acuitas Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acuitas Therapeutics

    • Figure Sales and Growth Rate Analysis of Acuitas Therapeutics

    • Figure Revenue and Market Share Analysis of Acuitas Therapeutics

    • Table Product and Service Introduction of Acuitas Therapeutics

    • Table Company Profile and Development Status of Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Figure Sales and Growth Rate Analysis of Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Figure Revenue and Market Share Analysis of Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Table Product and Service Introduction of Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Silence Therapeutics Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics Plc

    • Figure Sales and Growth Rate Analysis of Silence Therapeutics Plc

    • Figure Revenue and Market Share Analysis of Silence Therapeutics Plc

    • Table Product and Service Introduction of Silence Therapeutics Plc

    • Table Company Profile and Development Status of Antisense Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisense Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Antisense Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Antisense Therapeutics Ltd

    • Table Product and Service Introduction of Antisense Therapeutics Ltd

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of OncoGeneX Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OncoGeneX Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of OncoGeneX Pharmaceuticals

    • Figure Revenue and Market Share Analysis of OncoGeneX Pharmaceuticals

    • Table Product and Service Introduction of OncoGeneX Pharmaceuticals

    • Table Company Profile and Development Status of Bio-Path Holdings Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Path Holdings Inc

    • Figure Sales and Growth Rate Analysis of Bio-Path Holdings Inc

    • Figure Revenue and Market Share Analysis of Bio-Path Holdings Inc

    • Table Product and Service Introduction of Bio-Path Holdings Inc

    • Table Company Profile and Development Status of Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Figure Sales and Growth Rate Analysis of Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Figure Revenue and Market Share Analysis of Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Table Product and Service Introduction of Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Table Company Profile and Development Status of Benitec Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma

    • Figure Sales and Growth Rate Analysis of Benitec Biopharma

    • Figure Revenue and Market Share Analysis of Benitec Biopharma

    • Table Product and Service Introduction of Benitec Biopharma

    • Table Company Profile and Development Status of Lorus Therapeutics (Aptose Biosciences)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lorus Therapeutics (Aptose Biosciences)

    • Figure Sales and Growth Rate Analysis of Lorus Therapeutics (Aptose Biosciences)

    • Figure Revenue and Market Share Analysis of Lorus Therapeutics (Aptose Biosciences)

    • Table Product and Service Introduction of Lorus Therapeutics (Aptose Biosciences)

    • Table Company Profile and Development Status of Sanofi-Genzyme

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Genzyme

    • Figure Sales and Growth Rate Analysis of Sanofi-Genzyme

    • Figure Revenue and Market Share Analysis of Sanofi-Genzyme

    • Table Product and Service Introduction of Sanofi-Genzyme

    • Table Company Profile and Development Status of Gene Signal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gene Signal

    • Figure Sales and Growth Rate Analysis of Gene Signal

    • Figure Revenue and Market Share Analysis of Gene Signal

    • Table Product and Service Introduction of Gene Signal

    • Table Company Profile and Development Status of Gradalis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis

    • Figure Sales and Growth Rate Analysis of Gradalis

    • Figure Revenue and Market Share Analysis of Gradalis

    • Table Product and Service Introduction of Gradalis

    • Table Company Profile and Development Status of Quark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals

    • Table Product and Service Introduction of Quark Pharmaceuticals

    • Table Company Profile and Development Status of miRagen Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics

    • Figure Sales and Growth Rate Analysis of miRagen Therapeutics

    • Figure Revenue and Market Share Analysis of miRagen Therapeutics

    • Table Product and Service Introduction of miRagen Therapeutics

    • Table Company Profile and Development Status of Marina Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marina Biosciences

    • Figure Sales and Growth Rate Analysis of Marina Biosciences

    • Figure Revenue and Market Share Analysis of Marina Biosciences

    • Table Product and Service Introduction of Marina Biosciences

    • Table Company Profile and Development Status of iCo Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of iCo Therapeutics

    • Figure Sales and Growth Rate Analysis of iCo Therapeutics

    • Figure Revenue and Market Share Analysis of iCo Therapeutics

    • Table Product and Service Introduction of iCo Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US